The paracaspase MALT1 is a downstream target of Smad3 and potentiates the crosstalk between TGF-beta and NF-kB signaling pathways in cancer cells

TGF-beta signaling mediates its biological effects by engaging canonical Smad proteins and crosstalking extensively with other signaling networks, including the NF-kB pathway. The paracaspase MALT1 is an intracellular signaling molecule essential for NF-kB activation downstream of several key cell surface receptors. Despite intensive research on TGF-beta and NF-kB interactions, the significance of MALT1 in this context remains unde-coded. Here we provide experimental evidence supporting that MALT1 functions to converge these pathways. Using A549 and Huh7 cancer cell line models, we report that TGF-beta stimulation enhances MALT1 protein and transcript levels in a time-and dose-dependent manner. Systematic and selective perturbation of TGF-beta signaling components identifies MALT1 as a downstream target of Smad3. Rescue experiments in SMAD3 knockout cells confirm that C-terminal phosphorylation of Smad3 is central to MALT1 induction. Corroborating these data, we document that the expression of SMAD3 and MALT1 genes are positively correlated in TCGA cohorts, and we trace the molecular basis of MALT1 elevation to promoter activation. Functional studies in parental as well as NF-kB p65 signaling reporter engineered cells conclusively reveal that MALT1 is paramount for TGF-beta-stimulated nuclear translocation and transcriptional activation of NF-kB p65. Furthermore, we find that BCL10 is also implicated in TGF-beta activation of NF-kB target genes, potentially coupling the TGF-beta-MALT1-NF-kB signaling axis to the CARMA-BCL10-MALT1 (CBM) signalosome. The novel findings of this study indicate that MALT1 is a downstream target of the canonical TGF-beta/Smad3 pathway and plays a critical role in modulating TGF-beta and NF-kB crosstalk in cancer